Selected research
Market Structure
Global Ligases Enzymes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ligases Enzymes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ligases Enzymes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ligases Enzymes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ligases Enzymes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ligases Enzymes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ligases Enzymes include Agilent, BioRad, Illumina, Inc., New England Biolabs, Promega, QIAGEN, Roche, Takara and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Ligases Enzymes output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Ligases Enzymes by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Ligases Enzymes market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ligases Enzymes and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ligases Enzymes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ligases Enzymes market size, projected growth trends, production technologies, key applications, and end-use industries.
Ligases Enzymes Segment by Company
Agilent
BioRad
Illumina, Inc.
New England Biolabs
Promega
QIAGEN
Roche
Takara
Thermo Fisher Scientific
Abclonal
Fapon Biotech Inc
Novoprotein
CWbio
Vazyme
TransGen Biotech
Yeasen
Ligases Enzymes Segment by Type
DNA Ligase
RNA Ligase
Ligases Enzymes Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Academic & Research Institutes
Others
Ligases Enzymes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ligases Enzymes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ligases Enzymes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ligases Enzymes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ligases Enzymes market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ligases Enzymes industry.
Chapter 3: Detailed analysis of Ligases Enzymes market competition landscape. Including Ligases Enzymes manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Ligases Enzymes by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Ligases Enzymes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Ligase
- RNA Ligase
Applications
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Centers
- Academic & Research Institutes
- Others
Companies covered
- Agilent
- BioRad
- Illumina, Inc.
- New England Biolabs
- Promega
- QIAGEN
- Roche
- Takara
- Thermo Fisher Scientific
- Abclonal
- Fapon Biotech Inc
- Novoprotein
- CWbio
- Vazyme
- TransGen Biotech
- Yeasen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ligases Enzymes Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Ligases Enzymes Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Ligases Enzymes Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Ligases Enzymes Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Ligases Enzymes Market Dynamics
- 2.1 Ligases Enzymes Industry Trends
- 2.2 Ligases Enzymes Industry Drivers
- 2.3 Ligases Enzymes Industry Opportunities and Challenges
- 2.4 Ligases Enzymes Industry Restraints
3 Ligases Enzymes Market by Manufacturers
- 3.1 Global Ligases Enzymes Production Value by Manufacturers (2021-2026)
- 3.2 Global Ligases Enzymes Production by Manufacturers (2021-2026)
- 3.3 Global Ligases Enzymes Average Price by Manufacturers (2021-2026)
- 3.4 Global Ligases Enzymes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ligases Enzymes Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ligases Enzymes Manufacturers, Product Type & Application
- 3.7 Global Ligases Enzymes Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ligases Enzymes Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ligases Enzymes Players Market Share by Production Value in 2025
- 3.8.3 2025 Ligases Enzymes Tier 1, Tier 2, and Tier 3
4 Ligases Enzymes Market by Type
- 4.1 Ligases Enzymes Type Introduction
- 4.1.1 DNA Ligase
- 4.1.2 RNA Ligase
- 4.2 Global Ligases Enzymes Production by Type
- 4.2.1 Global Ligases Enzymes Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ligases Enzymes Production by Type (2021-2032)
- 4.2.3 Global Ligases Enzymes Production Market Share by Type (2021-2032)
- 4.3 Global Ligases Enzymes Production Value by Type
- 4.3.1 Global Ligases Enzymes Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ligases Enzymes Production Value by Type (2021-2032)
- 4.3.3 Global Ligases Enzymes Production Value Market Share by Type (2021-2032)
5 Ligases Enzymes Market by Application
- 5.1 Ligases Enzymes Application Introduction
- 5.1.1 Pharmaceutical & Biotechnology Companies
- 5.1.2 Hospitals & Diagnostic Centers
- 5.1.3 Academic & Research Institutes
- 5.1.4 Others
- 5.2 Global Ligases Enzymes Production by Application
- 5.2.1 Global Ligases Enzymes Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ligases Enzymes Production by Application (2021-2032)
- 5.2.3 Global Ligases Enzymes Production Market Share by Application (2021-2032)
- 5.3 Global Ligases Enzymes Production Value by Application
- 5.3.1 Global Ligases Enzymes Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ligases Enzymes Production Value by Application (2021-2032)
- 5.3.3 Global Ligases Enzymes Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Agilent
- 6.1.1 Agilent Company Information
- 6.1.2 Agilent Business Overview
- 6.1.3 Agilent Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.1.4 Agilent Ligases Enzymes Product Portfolio
- 6.1.5 Agilent Recent Developments
- 6.2 BioRad
- 6.2.1 BioRad Company Information
- 6.2.2 BioRad Business Overview
- 6.2.3 BioRad Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.2.4 BioRad Ligases Enzymes Product Portfolio
- 6.2.5 BioRad Recent Developments
- 6.3 Illumina, Inc.
- 6.3.1 Illumina, Inc. Company Information
- 6.3.2 Illumina, Inc. Business Overview
- 6.3.3 Illumina, Inc. Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.3.4 Illumina, Inc. Ligases Enzymes Product Portfolio
- 6.3.5 Illumina, Inc. Recent Developments
- 6.4 New England Biolabs
- 6.4.1 New England Biolabs Company Information
- 6.4.2 New England Biolabs Business Overview
- 6.4.3 New England Biolabs Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.4.4 New England Biolabs Ligases Enzymes Product Portfolio
- 6.4.5 New England Biolabs Recent Developments
- 6.5 Promega
- 6.5.1 Promega Company Information
- 6.5.2 Promega Business Overview
- 6.5.3 Promega Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.5.4 Promega Ligases Enzymes Product Portfolio
- 6.5.5 Promega Recent Developments
- 6.6 QIAGEN
- 6.6.1 QIAGEN Company Information
- 6.6.2 QIAGEN Business Overview
- 6.6.3 QIAGEN Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.6.4 QIAGEN Ligases Enzymes Product Portfolio
- 6.6.5 QIAGEN Recent Developments
- 6.7 Roche
- 6.7.1 Roche Company Information
- 6.7.2 Roche Business Overview
- 6.7.3 Roche Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.7.4 Roche Ligases Enzymes Product Portfolio
- 6.7.5 Roche Recent Developments
- 6.8 Takara
- 6.8.1 Takara Company Information
- 6.8.2 Takara Business Overview
- 6.8.3 Takara Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.8.4 Takara Ligases Enzymes Product Portfolio
- 6.8.5 Takara Recent Developments
- 6.9 Thermo Fisher Scientific
- 6.9.1 Thermo Fisher Scientific Company Information
- 6.9.2 Thermo Fisher Scientific Business Overview
- 6.9.3 Thermo Fisher Scientific Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.9.4 Thermo Fisher Scientific Ligases Enzymes Product Portfolio
- 6.9.5 Thermo Fisher Scientific Recent Developments
- 6.10 Abclonal
- 6.10.1 Abclonal Company Information
- 6.10.2 Abclonal Business Overview
- 6.10.3 Abclonal Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.10.4 Abclonal Ligases Enzymes Product Portfolio
- 6.10.5 Abclonal Recent Developments
- 6.11 Fapon Biotech Inc
- 6.11.1 Fapon Biotech Inc Company Information
- 6.11.2 Fapon Biotech Inc Business Overview
- 6.11.3 Fapon Biotech Inc Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.11.4 Fapon Biotech Inc Ligases Enzymes Product Portfolio
- 6.11.5 Fapon Biotech Inc Recent Developments
- 6.12 Novoprotein
- 6.12.1 Novoprotein Company Information
- 6.12.2 Novoprotein Business Overview
- 6.12.3 Novoprotein Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.12.4 Novoprotein Ligases Enzymes Product Portfolio
- 6.12.5 Novoprotein Recent Developments
- 6.13 CWbio
- 6.13.1 CWbio Company Information
- 6.13.2 CWbio Business Overview
- 6.13.3 CWbio Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.13.4 CWbio Ligases Enzymes Product Portfolio
- 6.13.5 CWbio Recent Developments
- 6.14 Vazyme
- 6.14.1 Vazyme Company Information
- 6.14.2 Vazyme Business Overview
- 6.14.3 Vazyme Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.14.4 Vazyme Ligases Enzymes Product Portfolio
- 6.14.5 Vazyme Recent Developments
- 6.15 TransGen Biotech
- 6.15.1 TransGen Biotech Company Information
- 6.15.2 TransGen Biotech Business Overview
- 6.15.3 TransGen Biotech Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.15.4 TransGen Biotech Ligases Enzymes Product Portfolio
- 6.15.5 TransGen Biotech Recent Developments
- 6.16 Yeasen
- 6.16.1 Yeasen Company Information
- 6.16.2 Yeasen Business Overview
- 6.16.3 Yeasen Ligases Enzymes Production, Value and Gross Margin (2021-2026)
- 6.16.4 Yeasen Ligases Enzymes Product Portfolio
- 6.16.5 Yeasen Recent Developments
7 Global Ligases Enzymes Production by Region
- 7.1 Global Ligases Enzymes Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Ligases Enzymes Production by Region (2021-2032)
- 7.2.1 Global Ligases Enzymes Production by Region (2021-2026)
- 7.2.2 Global Ligases Enzymes Production Forecast by Region (2027-2032)
- 7.3 Global Ligases Enzymes Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Ligases Enzymes Production Value by Region (2021-2032)
- 7.4.1 Global Ligases Enzymes Production Value by Region (2021-2026)
- 7.4.2 Global Ligases Enzymes Production Value by Region (2027-2032)
- 7.5 Global Ligases Enzymes Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Ligases Enzymes Production Value (2021-2032)
- 7.6.2 Europe Ligases Enzymes Production Value (2021-2032)
- 7.6.3 Asia-Pacific Ligases Enzymes Production Value (2021-2032)
- 7.6.4 South America Ligases Enzymes Production Value (2021-2032)
- 7.6.5 Middle East & Africa Ligases Enzymes Production Value (2021-2032)
8 Global Ligases Enzymes Consumption by Region
- 8.1 Global Ligases Enzymes Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Ligases Enzymes Consumption by Region (2021-2032)
- 8.2.1 Global Ligases Enzymes Consumption by Region (2021-2026)
- 8.2.2 Global Ligases Enzymes Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Ligases Enzymes Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Ligases Enzymes Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Ligases Enzymes Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Ligases Enzymes Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Ligases Enzymes Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Ligases Enzymes Value Chain Analysis
- 9.1.1 Ligases Enzymes Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ligases Enzymes Production Mode & Process
- 9.2 Ligases Enzymes Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ligases Enzymes Distributors
- 9.2.3 Ligases Enzymes Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst